Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.25 -1.2% 20.50 59,665 09:00:08
Bid Price Offer Price High Price Low Price Open Price
20.00 21.00 20.75 20.50 20.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1.52 5.71 6.65 3.1 18
Last Trade Time Trade Type Trade Size Trade Price Currency
15:33:24 O 4,805 20.56 GBX

Optibiotix Health (OPTI) Latest News

More Optibiotix Health News
Optibiotix Health Investors    Optibiotix Health Takeover Rumours

Optibiotix Health (OPTI) Discussions and Chat

Optibiotix Health Forums and Chat

Date Time Title Posts
27/6/202217:08OptiBiotix - The uncensored thread 60,114
27/6/202209:42OptiBiotix Health PLC - 16,704
13/5/202210:41OptiBiotix - Better Science, Better Health. Better buy some!58,100
11/2/202215:16OptiBiotix Health (Facts NOT Fiction)5,379
01/2/202121:24SentimentalRules AKA idoflykathy77

Add a New Thread

Optibiotix Health (OPTI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:33:2520.564,805987.91O
10:54:1920.013,000600.30O
10:26:4620.6716,5003,409.73O
08:40:5520.7514,4572,999.80O
08:00:0821.00859180.39UT
View all Optibiotix Health trades in real-time

Optibiotix Health (OPTI) Top Chat Posts

DateSubject
27/6/2022
09:20
Optibiotix Health Daily Update: Optibiotix Health Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 20.75p.
Optibiotix Health Plc has a 4 week average price of 20.50p and a 12 week average price of 20.50p.
The 1 year high share price is 57.50p while the 1 year low share price is currently 20.50p.
There are currently 88,065,661 shares in issue and the average daily traded volume is 37,245 shares. The market capitalisation of Optibiotix Health Plc is £18,053,460.51.
16/6/2022
11:15
putinaire: Just checked out fair values for opti and sbtx If we go to those, be nearly 100% falls from share price highs
10/6/2022
17:30
vlad the impaler: Certainly is a change in MO. Can't think of any reason apart from praying sbtx went up and a year selling it down hence de-risking sbtx holders and also opti holders, with no deals that so far had cost share price nearly 80% at one a week
01/5/2022
21:14
vlad the impaler: What you fail to address re cash from sbtx sales etc, is the fact that the market has discounted it as a value to opti shareholders The market is also discounting PBX cash value in opti holdings , currently. This is simply fact in share price terms In all the things you highlight as positive, it is down nearly 80% in the window . Example potential IPO known since Sept 2018 . Summary: Currently, the market wholly disagrees with you
01/5/2022
21:11
kreature: "How can you expect Opti share price to do well when it just got asset stripped?" More like asset-gang-raped when you consider the price paid ?
01/5/2022
18:24
vlad the impaler: In basic essence, the CLN was a transfer of ownership PBX could only go to IPO with something sellable in a brochure be it assets, cash or both . Plus whatever customers and so on. Patents ? Trademarks! I don't know the list Where all that come from? Basically CLN holders took value from opti to flog to another bunch of gerbils elsewhere How can you expect Opti share price to do well when it just got asset stripped? And market, looking at sbtx etc, have little to no faith in opti returns for real cash lol. IE market does not think the cash from sbtx will be of any value to them . That's the history so I'm sure they expect same of opti and PBX stock Was a great get rich quick scheme. And give the gerbils a few porridge tokens (call it div reward lol) to shut them up 😂 De-Risk.....a fair few Aim companies coming out with that one now. Must be the new trend
07/4/2022
19:25
vlad the impaler: The CEO says the spin outs are about de-risking shareholders. He is the largest holder at around 11% or so right? ['''OptiBiotix plc has subscribed for £250,000 of CLNs. Steve O'Hara, a director of the Company, has subscribed for £25,000 and certain close family members of Mr. O'Hara have subscribed for £265,000. In addition, Per Rehné, a director of the Company, has subscribed for £25,000. The remaining subscribers include two institutional investors and two industry partners....] Ok so, it seems between the free shares on his opti 11%, plus the £290,000 of CEO and family..... seems so de-risked ---- it is now -100% risk? Seems to be the biggest benefactor of the IPO in about 10 ways So, hmmm, if it was me, the asset transfer by opti would have now become 50 million lol Just to crunch numbers, what is the IPO plus free stock on opti holdings estimated to be worth? Did he mean de-risk or 'retire nicely' Either way, CEO and family will be by far , richer than opti for it all I hope opti pays a massive bonus for the spinout too.
01/4/2022
17:06
vlad the impaler: OPTI is being bled/stripped for the next IPO OPTI shareholders been paying 3% yield to CLN holders for years too OPTI has delivered nothing only spin off cash cows and terrible financials You speak of div paying holders yet you cant give a figure, and it could be little to nothing once able to realise it. You also fail to note, those who can only assuredly make on the IPO, in essence,....already have You also fail to note that the average price paid for OPTI stock by volume/transaction, is above 84p That Sir, means nothing is paying, no matter what spin you put on it ..................... SOme say, look at sbtx... sure, what a show lol. But here they say a spin off is to de-risk opti holders Just to define that, it means spinning out risk to take risk from opti holders, but can reward opti holders .............. It has not happened
01/4/2022
15:37
vlad the impaler: Mad Vlad shall answer Very cool. But it requires 1. faith to continue in management And 2.in the niche sector that, tbf, has been poor globally and not showing signs of lifting off. An interesting view. However, if you were to apply valuation methods, or what is known of them , say Sachs, Blackrock, JPM, and co, you get a valuation of OPTI circa 5.7p FV and SBTX 2.7p FV This would be the outcome based on current known financials, but, if applying that FV model..there are many ......... So what you are doing is looking to forward FV, rather than assessing what is, quite correctly, the current FV's as above Therein you have to apply whatever risk modelling you wish, and a score for each board/ceo based on how you view those historically, and so forth Valuations are very subjective, and there are many modelling forms. A lot of variables apply, and most likely, those will be inputted according to risk tolerance and such Here is the problem. You see 100p looking forward, but...you must admit, from a very very very poor current fact base. Both in terms of CEO scoring and more off the regulated string, suggestions Given the returns percentage one is seeking, there are far bigger, better, profitable, div paying companies out there with same potential, and far lower risk To accept risk here based on my own valuation/risk format, i would have to see at least 300p potential as reward, to divert some capital to the risk Obviously, i do not see that Far from it But as SR referred to before, if you are playing other market re the share price BS Market, fair enough You are betting on past failures, shocking financials, and poor board scoring, to hit what you hope to hit Also, it must be noted , OPTI sells and holdings on sbtx SP has dropped quite a lot in the phase of realisation and so forth That suggests to me, the market does not see any future value in how the company may use that cash re.... market not seeing it as any benefit to the common shareholder But as it goes, everyone will be of different opinion. That's why markets are what they are
31/3/2022
13:52
sentiment riles: RNS 4428K 2018 OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that further to the announcement on 24 September 2018 regarding the formation of the Company's wholly owned subsidiary ProBiotix Health Limited ("ProBiotix"), ProBiotix has raised £1.025 million of capital through the issue of convertible loan notes ("CLN"). The proceeds from the issue of CLNs will be used to provide funding for a potential initial public offering of ProBiotix. This is in line with OptiBiotix's strategy announced on 5 July 2016 to form separate divisions, which could in due course become separate legal entities with the potential for a separate public listing. OptiBiotix's strategy is based on its belief that the diversity of IP and commercial relationships across its four divisions reduces shareholder risk whilst offering multiple opportunities for value enhancement. OptiBiotix plc has subscribed for £250,000 of CLNs. Steve O'Hara, a director of the Company, has subscribed for £25,000 and certain close family members of Mr. O'Hara have subscribed for £265,000. In addition, Per Rehné, a director of the Company, has subscribed for £25,000. The remaining subscribers include two institutional investors and two industry partners. The CLNs can be converted at a fifty per cent. discount to the issue price of ProBiotix shares in the event of an IPO. The CLNs carry an interest rate of 3% per annum above the Bank of England Base Rate. As of 14 December 2018, Steve O'Hara has an interest in 10,103,029 ordinary shares in the Company, representing 11.9 per cent. of the Company's issued share capital and has an interest in a further 6,099,135 ordinary shares under option.
31/3/2022
12:45
sentiment riles: The other problem is this. "Sales attributed to Probiotix" These are now LPLDL sales? that can't also be attributed to opti , one would think . Or if so, need immediate deduction on EARNINGS day So , sales (no mention of probiotix operating profit on them ), have left opti? Or about to LPLDL re the whole foundation of marketing to investors for opti, is gone with those sales too? Along with 27 patents and 22 trademarks ? That will be an interesting £ write down to note on opti intangibles ? and how much value these actually had in opti balance sheet I know they call it de-risking but others call it asset stripping I'm just wondering is there any point investing in opti when basically a spin out machine of anything worth more then a quid Have I got that right ? Sales taken out of accounts plus high value intangibles on BS they now can't account for ? Isn't this whole thing just a transfer of wealth to a few? Not really value creation for opti at all ? Sure they can sell stock like in sbtx , but that just seems to lead to more de-risking (asset stripping ) spinning Have I got it wrong ?
Optibiotix Health share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
OPTI
Optibiotix..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220627 22:15:23